EWA
GNLX icon

EverSource Wealth Advisors’s Genelux GNLX Stock Holding History

EverSource Wealth Advisors’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-150
Closed -$654 – 4444
2025
Q4 		$654 Hold
150
– – ﹤0.01% 3805
2025
Q3 		$630 Buy
+150
New +$533 ﹤0.01% 3882

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $220M AUM 30.39% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EverSource Wealth Advisors's GNLX Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Genelux (GNLX) in Q1 2026, closing a stake of 150 shares — an estimated $654 sold.

EverSource Wealth Advisors first reported a position in GNLX in Q3 2025 and held it in 2 quarters. The position peaked at $654 in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • EverSource Wealth Advisors reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 150 Genelux shares in Q1 2026, an estimated $654.
  • EverSource Wealth Advisors first reported a position in Genelux in Q3 2025 and held it in 2 quarters.
  • EverSource Wealth Advisors's Genelux position peaked at $654 in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.